Clinical Trial Update: PARACHUTE China Approval Trial [NA]

View source ↗

Summary

The PARACHUTE China Approval Trial sponsored by CardioKinetix has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Failure

Drugs mentioned

• PARACHUTE

Snippet

Sponsor: CardioKinetix, Inc | Conditions: Ischemic Heart Failure | NA | Status: TERMINATED